Markets
Sangrix Inc. (SGRX)
SGRXNASDAQ-CMFinance: Consumer Services
$0.3910
-0.0380 (-8.86%) today
At the close, Nov 12, 4:00 PM ET. After hours $0.3930 -2.67%
-8.86% 1D
- Market cap
- $1.67m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $0.3800 to $0.4100
- 52-week range
- $0.3000 to $96.61
- Average volume
- –
- Previous close
- $0.4290
Financials
| Quarter | Jun 2016 |
|---|---|
| Revenue | $34.63m |
| Gross profit | $4.95m |
| Operating income | $2.73m |
| Net income | $2.18m |
News
8 latest- Bit Origin To Implement 1-For-5 Reverse Stock Split To Meet Nasdaq Requirements RTTNews · Aug 19, 2026
- Bit Origin Ltd Announces Initial Purchase of 40.5 Million DOGE as Part of Digital Asset Treasury InitiativeQuiver Quantitative · Jul 21, 2025
- Bit Origin Ltd Becomes First Publicly Listed Company to Establish Dogecoin Treasury Strategy on Major US ExchangeQuiver Quantitative · Jul 17, 2025
- Bit Origin Ltd Regains Compliance with Nasdaq Equity StandardQuiver Quantitative · Jul 3, 2025
- Bit Origin Ltd Seeks Court Confirmation for Share Capital Reduction Scheduled for June 5, 2025Quiver Quantitative · May 16, 2025
- Bit Origin Ltd Faces Nasdaq Compliance ChallengeTipRanks · Jan 8, 2025
- Bit Origin Ltd Notifies Nasdaq of Non-Compliance with Stockholders' Equity RequirementQuiver Quantitative · Jan 8, 2025
- Bit Origin Ltd Regains Nasdaq ComplianceTipRanks · Jan 2, 2025
The company
SANGRIX INC. (NASDAQ: SGRX), formerly Bit Origin Ltd, is pursuing a strategic transition toward infrastructure supporting artificial intelligence workloads. Its areas of focus include GPU computing, server leasing, storage infrastructure and associated services. Alongside these initiatives, the Company continues to oversee its existing digital asset holdings and legacy business activities.
- Sector
- Finance
- Industry
- Finance: Consumer Services
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- bitorigin.io
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.